Reduction and uptake of methylene blue by human erythrocytes (2004)

Peer-Reviewed Study · James M. May, Zhi-chao Qu, Charles E. Cobb · February 18, 2004

James M. May et al., 2004-02-18: Human erythrocyte study showing the dye is reduced extracellularly, then taken up and partly reoxidised, with both forms concentrated in the cell and redox cycling causing oxidant stress that consumes NAD(P)H first and glutathione/ascorbate at higher concentrations.

erythrocytes sequentially reduce and take up MB(+), that both reduced and oxidized forms of the dye are concentrated in cells, and that the thiazine dye reductase activity initially responsible for MB(+) reduction may correspond to MB(+)-dependent NAD(P)H reductase activity in erythrocyte ghosts.

Abstract

James M. May et al., 2004-02-18: Human erythrocyte study showing the dye is reduced extracellularly, then taken up and partly reoxidised, with both forms concentrated in the cell and redox cycling causing oxidant stress that consumes NAD(P)H first and glutathione/ascorbate at higher concentrations. Laboratory study in human erythrocytes and ghosts (no living subjects). Country: United States (Vanderbilt University). Concentrations: MB+ below 5 microM selectively oxidised NAD(P)H; higher concentrations also oxidised glutathione and ascorbate. Route: in vitro. Funder: NIH NIDDK DK-50435. Conflicts: none declared. Comparator: cells without dye; glucose-free vs glucose-containing incubations; trypsin and phenylarsine oxide as mechanistic probes. Relevant to the blood-to-plasma partitioning on the label (MTJ-28): most of the dye sits in cells, so whole-blood and plasma half-lives are not the same measurement. Study type: lab.